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Abstrak 
 
Dalam rangka mendapatkan turunan antibiotik C-9154 yang cukup 
aktif, di dalam penelitian ini telah dilakukan sintesis dan uji aktifitas 
antibakteri terhadap p-anisil etil fumarat dan etil N-fenil fumaramat. Kedua 
molekul target tersebut dipilih dengan pertimbangan bahwa p-anisil etil 
fumarat akan merupakan turunan antibiotik C-9154 yang memiliki substituen 
metoksi pada posisi para, sedangkan etil N-fenil fumaramat akan menjadi 
contoh turunan antibiotik C-9154 tanpa substituen yang berada dalam 
bentuk amido-ester.  
Pembuatan p-anisil etil fumarat dilakukan dari p-anisaldehida melalui 
reduksi menggunakan NaBH4, kondensasi p-anisil alkohol dengan maleat 
anhidrid, dan esterifikasi asam p-anisil maleat hasil dengan etanol 
menggunakan asam benzena sulfonat sebagai katalis. Keseluruhan tahapan 
reaksi tersebut memberikan rendemen hasil yang memuaskan (55-81 %). 
Dalam hal etil N-fenil fumaramat, senyawa ini diperoleh dengan rendemen   
84 % melalui kondensasi antara anilin dengan maleat anhidrid, diteruskan 
dengan esterifikasi asam N-fenil maleamat hasil dengan etanol menggunakan 
katalis asam sulfat pekat.  
Hasil uji khasiat antibakteri menunjukkan bahwa harga konsentrasi 
hambatan minimum (MIC) dari p-anisil etil fumarat dan etil N-fenil 
fumaramat terhadap Staphyllococcus aureus masing-masing adalah 15 dan 
25 µg/mL. Serupa dengan itu, harga MIC dari kedua senyawa tersebut 
terhadap Eschericia coli juga sebesar 15 dan 25 µg/mL. Data uji aktivitas 
antibakteri tersebut menunjukkan bahwa kedua senyawa turunan antibiotik 
C-9154 yang diperoleh adalah cukup aktif dan memiliki aktivitas antibakteri 
yang sebanding dengan harga aktivitas antibakteri dari antibiotik C-9154 
sendiri yang memberikan harga MIC 6,25 – 37,5 µg/mL terhadap beberapa 
spesies Staphyllococcus aureus dan 25 - 50 µg/mL terhadap sejumlah spesies 
Eschericia coli.  
Kata kunci: sintesis, anti bakteri, fumarat, dan fumaramat.  
 
Abstract 
 
In order to generate potent C-9154 antibiotic derivatives, it has been 
conducted the synthesis and antibacterial activity evaluation of  p-anisyl ethyl 
fumarate and ethyl N-phenyl fumaramate. These target molecules were 
chosen as the former would be a para-methoxy substituted C-9154 
derivative, whereas the latter would be an example of unsubstituted C-9154 
derivative bearing an amido-ester fumaric side chain.   
p-Anisyl ethyl fumarate was synthesized from p-anisaldehyde by 
reduction with NaBH4, condensation of p-anisyl alcohol with maleic 
anhydride, and esterification of the resulting p-anisyl maleic acid with ethanol 
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in the presence of benzenesulfonic acid as the catalyst. These reactions gave 
satisfactorily yields (55-81 %) in all steps involved. In the case of ethyl N-
phenyl fumaramate, this molecule was synthesized in 84 % yield through 
condensation of aniline with maleic anhydride, followed by esterification with 
ethanol in the presence of concentrated sulfuric acid.  
The antibacterial activity test showed that the minimum inhibition 
concentration (MIC) of p-anisyl ethyl fumarate and ethyl N-phenyl 
fumaramate towards Staphyllococcus aureus were 15 and 25 µg/mL. 
Interestingly, the MIC values of these two compounds towards Eschericia coli 
were also 15 and 25 µg/mL respectively. Thus, the data showed that the two 
C-9154 derivatives obtained are sufficiently potent and possess antibacterial 
activities which are comparable to the antibacterial activity of C-9154 itself 
towards Staphyllococcus aureus (12.5 – 37.5 µg/mL) and Eschericia coli     
(25 – 50 µg/mL).  
Key words: synthesis, antibacterial activity, fumarate and fumaramate.   
 
Introduction 
The derivatives of maleic acid (cis) and 
fumaric acid (trans) are two groups among the 
known compounds which have been used in 
the field of pharmacy, medicine, and agriculture 
since a long time ago. Specifically, the deriva-
tives of these two isomeric compounds have 
been utilized for the preparation of antibiotics, 
antifungis, antihistamins and plant growth 
regulators (Stecher, 1968). Just to mention 
some examples are the ester form of melanilic 
acid which has been patented as an antifungi 
(Ligett, 1968), A-19009 antibiotic discovered by 
Molloy et al.  (1972), fumaryl DL-alanin anti-
biotic, and maleic hydrazides which are known 
to be able to inhibit the growth of several 
horticulture plants (Birkingshaw et al. , 1942). In 
addition, combination of maleic acid and 
chlorpheniramine known as chlorpheniramine 
maleate is commonly found in some cough 
formulaes such as Benadryl, Formula 44 and 
Alerin.  
Beside the active compounds as stated 
above, fumaric fragment also becomes part of 
the structure of C-9154 antibiotic. C-9154 (1) is 
a class of antibiotic isolated from Streptomyces 
ishigakiensis (Hasegawa et. al., 1975) or Streptomy-
ces kurssanovii (Maruyama et al. , 1975) through a 
fermentation process.  The compound showed 
a broad spectral activity against Gram-positive 
and Gram-negative bacteria such as Escherichia 
coli and Staphylococcus aureus with minimum 
inhibition concentration (MIC) varied from 10-
100 g/mL and LD50 in mice of 75 mg/kg. 
The chemical structure of C-9154 antibiotic 
itself basically consists of two fragments i.e. 
phenylacetic acid and fumaramide (Hasegawa 
et.al, 1975; Suhara et al. , 1975). 
A new strategy for the synthesis of        
C-9154 antibiotic derivatives from vanillin has 
been developed recently by our research group 
(Jumina et.al, 2000 and 2001). Within this 
strategy, vanillin was converted to 4-ethoxy-3-
methoxybenzylaniline in three stages. This 
benzylaniline was then reacted with maleic 
anhydride to be followed by esterification of 
the related acid with absolute ethanol in the 
presence of H2SO4. This method is very 
efficient and satisfactory yields (70-95%) were 
obtained in each step. The biological activity of 
both C-9154 derivatives obtained (2 and 3) 
have already been investigated in which the 
MIC of 2 towards Staphyllococcus aureus and 
Escherichia coli were 2500-3000 µg/mL, whereas 
that of 3 towards the same bacteria were 500-
1000 µg/mL. Thus, conversion of the carbo-
xylic acid group in 2 to an ester functionality in 
3 has led to an increase of anti microbe activity 
to approximately four times.  
The above method has also been 
extended on the case of 4-ethoxy-3-
methoxybenzyl alcohol simply prepared via 
reduction of ethyl vanillin with NaBH4. This 
type of benzyl alcohol derivatives was reacted 
with maleic anhydride to be followed by 
treatment with absolute ethanol in the presence 
of H2SO4. Again, excellent yields (78-93 %) 
were achieved in all steps. The acid form 4 of 
the derivative obtained still gave a weak anti 
microbe effect (MIC 2000-2500 µg/mL) 
towards Staphyllococcus aureus and Escherichia coli. 
However, a significant anti microbe activity 
towards those two microbes (MIC 400-700 
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µg/mL) were observed on the case of the ester 
derivative 5.    
More recently, C-9154 antibiotic 
derivatives have also been synthesized from 
methyl salicylate and furfural (Jumina et al. , 
2002). The preparation of C-9154 antibiotic 
derivative from methyl salicylate was conducted 
through reduction of methyl salicylate with 
lithium aluminium hydride, condensation of 
salicyl alcohol with maleic anhydride, and 
esterification of the resulting salicyl maleic acid 
with ethanol in the presence of benzenesulfonic 
acid to afford ethyl salicyl fumarate 6. In the 
case of furfural, the synthetic route performed 
were reduction of furfural with sodium 
borohydride, condensation of furfuryl alcohol 
with maleic anhydride, and esterification of the 
resulting furfuryl maleic acid with ethanol in the 
presence of benzenesulfonic acid to give ethyl 
furfuryl fumarate 7. This furfuryl fumarate ester 
7 showed significantly strong activities towards 
Staphyllococcus aureus and Escherichia coli with MIC 
of 100 µg/mL towards both bacteria. Ethyl 
salicyl fumarate 6 also demonstrated a sufficien-
tly strong activity towards Staphyllococcus aureus 
with MIC of 100 µg/mL, but this compound 
only exhibited a weak activity towards 
Escherichia coli with MIC of 4000 µg/mL.  
In order to obtain a more potent C-9154 
antibiotic derivatives, it was of interest to 
synthesize p-anisyl ethyl fumarate 8 and ethyl 
N-phenyl fumaramate 9. These target molecules 
were chosen as all would be less bulky than 
compound 2, 3, 4, 5, and 6 previously obtained. 
In addition, the aromatic moiety of target 
compound 9 would be exactly the same as that 
of C-9154 antibiotic. Thus, on the basis of 
molecular size and similarity of aromatic ring 
between the target molecules and C-9154 anti-
biotic, it was hoped that the target compound   
8 and 9 would be more potent than compound    
2, 3, 4, 5, 6, and 7 previously synthesized.  
 
Methodology 
Chemicals. All chemicals used in this 
research were reagent grade from E.Merck. 
Apparatus. The equipment used in this experiment 
involved JEOL MY60 proton NMR spectrometer, 
Shimadzu FTIR 8201 PC spectrophotometer, and 
Shimadzu QP 5000 Gas Chromatograph-Mass 
Spectrometer.  
 
Reduction of p-anisaldehyde 
Sodium borohydride (0.35 g; 9.2 mmol) was 
added into a solution of p-anisaldehyde (0.5 g; 3.67 
mmol) in absolute ethanol (4 ml). The mixture was 
stirred and heated at reflux for 3 hours, then the 
solvent was removed using a Buchii evaporator. The 
residue was diluted with water (15 ml), and extracted 
with dichloromethane (3x20 ml). The combined 
organic layers were washed with water (2x70 ml), 
dried over anhydrous sodium sulfate and evaporated 
to give a brown oil. This oil was passed through a 
suction silica-chromatographic column eluted with 
Figure 1. Structure of C-9154 antibiotic and its derivatives 
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dichloromethane/petroleum ether (7:3) to yield       
p-anicyl alcohol (0.30 g; 55%) as a light yellow oil. 
This product was identified by means of IR and 
GC-MS spectrometers.  
 
Condensation of p-anisyl alcohol with maleic 
anhydride 
A solution of p-anisyl alcohol (1.5 g, 10.87 
mmol) in benzene (5 mL) was added dropwise into a 
solution of maleic anhydride (1.28 g, 13.0 mmol) in 
benzene (10 mL). The mixture was stirred at 90oC 
for 2.5 h, then allowed to cool, and diluted with 
ethyl acetate (50 mL). The resulted solution was 
washed with water (3x70 mL), and the organic phase 
was dried over anhydrous sodium sulfate and 
evaporated to leave a white sticky solid. Recrystalli-
zation of this solid from ethanol afforded p-anisyl 
maleic acid as a white solid (2.01 g, 78 %). This       
p-anisyl maleic acid was characterized by means of 
IR, proton NMR, and GC-MS spectrometers.  
 
Synthesis of p-anisyl ethyl fumarate (deriva-
tive of C-9154) 
A mixture of p-anisyl maleic acid (1.0 g, 4.23 
mmol), absolute ethanol (10 mL), and benzene 
sulfonic acid (ca. 0.3 g) was stirred and heated at 
reflux for 3 h. The resulted mixture was allowed to 
cool, then the solvent was removed by means of 
rotary evaporator. The residue was diluted with 
water (40 mL), then extracted with dichloromethane 
(3x40 mL). The combined organic layers were 
washed with water (2x70 mL), dried over anhydrous 
sodium sulfate and evaporated to afford the desired 
ester which was found as a colorless oil. This oil was 
passed through a suction silica-chromatographic 
column eluted with dichloromethane/petroleum 
ether (4:1) to afford p-anisyl ethyl fumarate as a 
colorless oil (0.90 g, 81 %). This product was 
characterized by means of IR and proton NMR 
spectrometers.  
 
Condensation of aniline with maleic anhy-
dride 
Into a solution of maleic anhydride (5.0 g, 
51.0 mmol) in benzene (20 mL) was added in 
portions aniline (4.0 g, 43.0 mmol). The resulted 
emulsion was then heated at reflux for 2 h. The 
mixture was allowed to cool down, then diluted with 
ethanol (120 mL) and acidified using 5 % HCl 
solution. The resulted suspension was filtered, and 
the solid obtained was dried and recrystallized from 
dichloromethane/petroleum ether (1:1) to give N-
phenylmaleamic acid (6.2 g, 76 %) as a fine white 
solid.  
 
Synthesis of ethyl N-phenyl fumaramate (de-
rivative of C-9154) 
A mixture of N-phenyl maleamic acid (1.5 g, 
7.32 mmol), absolute ethanol (15 mL), and 
concentrated sulfuric acid (3 drops) was stirred and 
heated at reflux for 3 h. The resulted mixture was 
allowed to cool, then the solvent was removed by 
means of rotary evaporator. The residue was diluted 
with water (40 mL), then extracted with dichloro-
methane (3x40 mL). The combined organic layers 
were washed with water (2x70 mL), dried over 
anhydrous sodium sulfate and evaporated to leave a 
yellow oil. This oil was passed through a suction 
silica-chromatographic column eluted with dichloro-
methane/petroleum ether (4:1) to yield the desired 
ethyl ester (1.45 g, 84 %) as a light yellow oil. This 
product was characterized by means of IR and 
proton NMR spectrometers.  
 
Determination of anti bacterial activity of the 
derivatives synthesized 
A series of solutions of each C-9154 
derivative were prepared and placed in tubes 
containing Staphyllococcus aureus and Escherichia coli. 
The samples were incubated at 37oC, and the 
inhibition effect of each sample was observed.  
The C-9154 antibiotic derivatives obtained 
from the experiment were placed on petri dish 
containing Gram positive and negative bacteria. The 
samples were incubated at 37oC using agar media 
and the inhibition effect of each sample was 
observed. 
 
Result And Discussions 
Synthetic approaches to the targeted     
C-9154 antibiotic derivatives 
This experiment was designed in order 
to synthesize 2 types of C-9154 antibiotic 
derivatives i.e. p-anisyl ethyl fumarate and       
N-phenyl fumaramate. Whereas the first 
example would be a fumarate diester, the 
second target molecule will be a fumarate 
amido-ester. In the case of p-anisyl ethyl 
fumarate, the whole reactions performed 
consisted of reduction of p-anisaldehyde (8) 
with sodium borohydride, condensation of       
p-anisyl alcohol (9) with maleic anhydride, and 
esterification of p-anisyl maleic acid (10) with 
ethanol (Figure 2).  
The reduction of p-anisaldehyde with 
sodium borohydride was conducted in absolute 
ethanol at reflux for 3 hours to give the desired 
p-anisyl alcohol in 72 % yield which was found 
as light yellow oil. The reality that the reaction 
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required a relatively long time (3 hours) under a 
hard condition (78oC) could be correlated by 
the presence of the electron donating methoxy 
group which would decrease the reactivity of    
p-anisaldehyde carbonyl group towards 
nuchleophiles including hydride ions.  
The IR spectrum of the resulted p-anisyl 
alcohol clearly shows the existence of a strong 
broad band at 3383 cm-1 originating from the 
OH stretching frequency. In addition, the 
disappearance of C=O absorption, which arises 
at 1681 cm-1 in the IR spectrum of the starting 
material, gave more evidence for the success of 
the reduction. Other absorption bands arising 
at 3100-3000 cm-1 (CH stretching), 1600-1500 
cm-1 (C=C aromatic stretching), 1249 cm-1 (CH 
bending), and 1009 cm-1 (C-O stretching) also 
support the proposed structure.  
Further structural assignment of the 
product conducted using GC-MS gave a chro-
matogram which indicated that the product 
essentially consists of a single component        
(tR= 11.46 minutes, 91.5%). The mass spectrum 
of this major product gave a molecular ion peak 
at m/z = 138 which fits with the molecular 
weight of p-anisyl alcohol. Furthermore, frag-
ments arising at m/z = 121 and m/z = 109 in 
the mass spectrum are respectively originated 
from the loss of OH (M-17) and CO (M-28) 
groups.  
The resulted p-anisyl alcohol was then 
reacted with maleic anhydride in benzene at 70-
80oC for 2.5 hours to afford p-methoxybenzyl 
maleic acid in 86 % yield. Identification of the 
product was conducted by means of IR and 
mass spectrometers. The IR spectrum showed 
stretching frequencies of OH group (3200-3700 
cm-1, medium), C=O group (1780 and 1732 
cm-1), and C=C group (1612 and 1516 cm-1). 
The CH bending frequency of the alkyl groups 
appears at 1412-1463 cm-1 (weak), while the    
C-O stretching frequencies emerge as strong 
bands at 1175 and 1248 cm-1. Identification 
using GC-MS indicated that the product 
consisted of 4 main components in which the 
expected anisyl maleic acid (tR = 25.2 minutes) 
became the major component (60 %). The 
mass spectrum of this acid did not show 
molecular ion peak at the expected value (m/z 
236), but it revealed a molecular ion peak at 
m/z 240. However, the fragmentation pattern 
of the spectrum exhibiting peaks at m/z 91, 121 
(base peak), and 137 gave sufficient evidence 
for the formation of the desired p-anisyl maleic 
acid.   
The esterification of p-methoxybenzyl 
maleic acid was first performed with absolute 
ethanol in the presence of concentrated sulfuric 
acid, which has been becoming the most 
common catalyst for esterification reaction. 
The reaction mixture was heated at reflux for 4 
hours to be followed by evaporation of excess 
solvent and regular extraction to yield a light 
brown oil.  The results of identification using 
GC-MS indicated that this product consisted of 
two components having molecular ion peak at 
m/z 172 and 166. Based on this data and on the 
fragmentation pattern given in the mass 
spectra, it was concluded that these two 
components were diethyl maleat (43 %) and 
ethyl p-methoxybenzyl ether (44 %). The 
mechanism of the reaction apparently involved 
normal esterification of COOH side of            
p-methoxybenzylmaleic acid to be followed by 
CH3CH2OH attack of the benzylic carbon to 
yield p-methoxybenzyl ethyl ether and ethyl 
maleat monoacid. This last compound then 
underwent esterification further to form diethyl 
maleat.  
Figure 2 Synthetic scheme of p-anisyl ethyl fumarate
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The esterification of p-anisylmaleic acid 
with ethanol was then conducted using benze-
nesulfonic acid as the catalyst, which is weaker 
than sulfuric acid. The reaction was carried out 
at reflux for 3 hours to afford the desired ethyl 
p-anisylfumarate in 81 % yield which is presu-
mably formed via isomerization of ethyl          
p-anisylmaleate. This product was identified by 
means of proton NMR spectrum which gives 
two doublets at 6.90 and 7.25 ppm (5 H) of the 
phenyl protons and two singlets at 6.15 and 
6.25 ppm (2 H) of the fumaric CH=CH 
protons. The existence of CH2 and OCH3 
protons are respectively indicated by singlets at 
4.40 ppm (2 H) and 3.8 ppm (3 H). Likewise, 
the presence of CH2CH3 groups are indicated 
by quartet at 3.50 ppm (2 H) and triplet at 1.20 
ppm (3 H). Therefore, it is clear that the result 
of the esterification is the desired p-anisyl ethyl 
fumarate.  
The preparation of C-9154 antibiotic 
derivatives so far has been conducted towards 
p-anisyl alcohol. In these cases, the resulted     
C-9154 derivatives possess benzyl moiety 
existing as an ester. It was also of interest to 
prepare C-9154 derivatives from aniline in 
order to obtain C-9154 molecules having 
aromatic ring directly attached to the amide 
group. In this case the strategy consists of         
2 reaction steps i.e. condensation of aniline (12) 
with maleic anhydride and esterification of the 
resulted N-phenylmaleamic acid (13) (Figure 3).  
The condensation of aniline with maleic 
anhydride was conducted in diethyl ether at 
room temperature for 2 hour according to the 
method as described by Vogel (1968) to give   
92 % yield of the desired N-phenylmaleamic 
acid. The resulted N-phenylmaleamic acid was 
simply isolated through filtration. This 
molecule was then treated with absolute 
ethanol at reflux for 3 hours in the presence of 
concentrated sulfuric acid to afford the desired 
ethyl N-phenyl fumaramate in 76 % yield. 
Interestingly, when this esterification was 
performed using benzenesulfonic acid as the 
catalyst, the outcome was only starting material. 
Thus, it should be clear here that N-phenylma-
leamic acid is less reactive compared to           
p-anisylmaleic acid employed in the prepa-
ration of p-anisyl ethyl fumaramate.  
The IR spectrum of the above ethyl      
N-phenylmaleamate revealed NH absorption 
band at 3307 cm-1, C=O stretching frequency 
at 1716 cm-1, and C=C stretching frequencies at 
1548-1598 cm-1. The proton NMR spectrum 
showed 5 signals indicating the presence of      
5 types of protons. Broad singlet at 10.8 ppm     
(1 H) is originated from NH proton, whereas 
multiplet at 7.2-8.0 ppm (5 H) is corresponding 
to the aromatic protons. The appearance of a 
pair singlets at 6.3 and 6.4 ppm (2 H) clearly 
indicated the presence of CH=CH maleic 
protons. Similarly, the presence of a quartet at 
4.5 ppm (2 H) and a triplet at 1.3 ppm (3 H) are 
strong evidence for the existence of CH2CH3 
group.  
The chromatogram obtained from     
GC-MS showed that the product consisted of 
two components. On the basis of mass 
spectrum, the major component having 
retention time of 18.867 minutes gave 
molecular ion peak at m/z 219 which is 
consistent with the molecular weight of the 
expected N-phenyl ethyl fuma-ramate. Thus, on 
the basis of proton NMR and GC-MS data, it 
was strongly indicated that the outcome of the 
above reaction was N-phenyl ethyl fumaramate.  
 
Figure 3 Synthetic scheme of ethyl N-phenyl fumaramate
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Antibacterial evaluation 
The experiments carried out within this 
research so far have led to the generation of 
two examples of C-9154 antibiotic derivatives 
i.e. p-anisyl ethyl fumarate 11 and ethyl            
N-phenyl fumaramate 14. Antibacterial activity 
test towards these compounds was conducted 
using Staphyllococcus aureus (SA) dan Escherichia 
coli (EC) as the representative of Gram positive 
and Gram negative bacteria. The experiment 
was carried out using agar media and ethyl 
acetate as the solvent. The results of 
measurement of minimum inhibition concen-
tration (MIC) of the above compounds towards 
the growth of Staphyllococcus aureus (SA) and 
Escherichia coli (EC) are presented in Table I.  
It can be seen from Table I that the anti-
bacterial activity of p-anisyl ethyl fumarate 11 
towards both Staphyllococcus aureus and Escherichia 
coli are 15 µg/mL. Nevertheless, slightly weaker 
antibacterial activities were found in the case of 
ethyl N-phenyl fumaramate 14 giving MIC 
values of 25 µg/mL towards both Staphyllococcus 
aureus and Escherichia coli. Even though a direct 
comparison based on the structure of p-anisyl 
ethyl fumarate 11 and ethyl N-phenyl fuma-
ramate 14 is a bit difficult to be justified, the 
above data perhaps shows that the antibacterial 
activity of fumarate antibiotic derivatives are 
stronger when the molecules do present as 
diesters (as the case of p-anisyl ethyl fumarate 
11) rather than when the molecules present as 
amido-esters (as the case of ethyl N-phenyl 
fumaramate 14). In addition, the data perhaps 
also shows that the presence of additional 
lipophilic groups such as OCH3 and –CH2- in 
the structure of fumarate antibiotics could also 
slightly enhance their antibacterial activities. 
Furthermore, the data also shows that the 
activity of p-anisyl ethyl fumarate 11 and ethyl 
N-phenyl fumaramate 14 towards the Gram 
positive and Gram negative bacteria are the 
same. Therefore, the data proved that p-anisyl 
ethyl fumarate 11 and ethyl N-phenyl fuma-
ramate 14 are both sufficiently effective to 
inhibit the growth of the Gram positive and 
Gram negative bacteria.  
The activity of C-9154 antibiotic itself 
(Maruyama et al. , 1975; Hasegawa et al. , 1975) 
towards several types of Staphyllococcus aureus 
species (FDA 16, MS 3937, MS 4018, and MS 
9261) are ranging from 6.25 - 37.5 µg/mL. 
Slightly different, the activity of C-9154 anti-
biotic towards several types of Escherichia coli 
species (NIHJ, K12, K12 ML1630, and 
JR66/W677) lies in the range of 25 - 50 µg/mL. 
Therefore, it is clear that the activities given by 
the synthesized p-anisyl ethyl fumarate 11       
(15 µg/mL) and ethyl N-phenyl fumaramate 14 
(25 µg/mL) towards Staphyllococcus aureus and 
Escherichia coli are comparable or similar to 
those given by C-9154 antibiotic. Thus, this 
finding should be significantly valuable as the 
structures and the method of preparations of     
p-anisyl ethyl fumarate 11 and ethyl N-phenyl 
fumaramate 14 are much simpler than those of 
C-9154 antibiotic.  
 
Conclusions 
p-Anisyl ethyl fumarate 11 could be 
prepared in a good yield from p-anisaldehyde 
through reduction with sodium borohydride, 
condensation with maleic anhydride, and 
esterification with ethanol in the presence of 
benzenesulfonic acid as the catalyst. Likewise, 
ethyl N-phenyl fumaramate 14 could also be 
synthesized in a satisfactorily yield through 
condensation of aniline with maleic anhydride 
followed by esterification of the resulting       
N-phenyl maleic acid with ethanol in the 
presence of concentrated sulfuric acid as the 
catalyst.  
p-Anisyl ethyl fumarate 11 is sufficiently 
active to inhibit the growth of Staphyllococcus 
aureus and Eschericia coli with MIC value of  15 
µg/mL for both bacteria. Slightly weaker 
activities towards the same bacteria were seen 
in the case of ethyl N-phenyl fumaramate 14 
Tabel I MIC values of C-9154 antibiotic derivatives
Compound MIC SA (µg/mL) MIC EC (µg/mL) 
p-Anisyl ethyl fumarate 11 15 15 
Ethyl N-phenyl fumaramate 14 25 25 
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which give MIC value of 25 µg/mL. The 
antibacterial activities given by p-anisyl ethyl 
fumarate 11 and ethyl N-phenyl fumaramate 14 
towards Staphyllococcus aureus and Eschericia coli 
are already comparable to those of C-9154 
antibiotic towards the same bacteria.  
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